Hartman Institute for Therapeutic Organ Regeneration

Pancreas regeneration.

TitlePancreas regeneration.
Publication TypeJournal Article
Year of Publication2018
AuthorsZhou Q, Melton DA
JournalNature
Volume557
Issue7705
Pagination351-358
Date Published2018 May
ISSN1476-4687
KeywordsAdult Stem Cells, Animals, Cell Proliferation, Cellular Reprogramming, Humans, Islets of Langerhans, Pancreas, Pluripotent Stem Cells, Regeneration, Regenerative Medicine
Abstract

<p>The pancreas is made from two distinct components: the exocrine pancreas, a reservoir of digestive enzymes, and the endocrine islets, the source of the vital metabolic hormone insulin. Human islets possess limited regenerative ability; loss of islet β-cells in diseases such as type 1 diabetes requires therapeutic intervention. The leading strategy for restoration of β-cell mass is through the generation and transplantation of new β-cells derived from human pluripotent stem cells. Other approaches include stimulating endogenous β-cell proliferation, reprogramming non-β-cells to β-like cells, and harvesting islets from genetically engineered animals. Together these approaches form a rich pipeline of therapeutic development for pancreatic regeneration.</p>

DOI10.1038/s41586-018-0088-0
Alternate JournalNature
PubMed ID29769672
PubMed Central IDPMC6168194
Grant ListR01 DK106253 / DK / NIDDK NIH HHS / United States
UC4 DK116280 / DK / NIDDK NIH HHS / United States
/ HHMI / Howard Hughes Medical Institute / United States

Weill Cornell Medicine
Hartman Institute for Therapeutic Organ Regeneration
1300 York Ave, Box 136 New York, NY 10065